Synthelia Organics SL is pleased to announce the launch of its fully featured website www.synthelia.com. The new site has extensive content including all the services provided by Synthelia and the complete catalog of products. Synthelia organics website is designed to assist to those professionals who look for a trustworthy chemistry partner in pharmaceutical industry. The…Details
Nature has afforded us 22 naturally occurring coded amino acids commonly found in proteins isolated from eukaryotic and prokaryotic sources. A variety of synthetic means have also been established to produce a great amount of non-proteinogenic amino acids as tools to investigate enzymatic mechanisms, extend biological half-life, establish a specific conformational determinant or increase potency…Details
Synthelia Organics launchs the new product catalogue, which highlights its extensive scope of products.
The new 42-products catalog clearly illustrates the great scope of products that Synthelia could provide to its customers: from boronic acids, to aminoacids, heterocycles or chiral aminoalcohols. These intermediates are widely exemplified in diverse patent applications in literature or presented in multiple medchem groups SARs. These materials come from the experience of Synthelia Organics in…Details
Synthelia Organics a new collaborator with the Master in Organic Chemistry at the Universidad Autónoma de Madrid.
Synthelia Organics is included as a partner of the Universidad Autonoma de Madrid for the practical formation of the MS student in organic chemistry. Synthelia offers its installation for the technical formation of the students in the different techniques used in organic chemistry, synthesis, purification and analysis of synthetic compounds. The main objective of the…Details
Synthelia in collaboration with Prof. José Alemán and Prof. Silvia Cabrera has just published its latest scientific researches concerning flow photocatalytic oxidation of thioethers using a novel Pt(II) cat. The continuous photooxidation process has been development in a reactor based on a FEP capillary coil wherein a combination of thiether and catalyst (1 mol%) were…Details
The Daptomincine was the last antibiotic included into the war against the bacterias and it was in 1987. Now a research group led by Losee Ling, from NovoBiotic Pharmaceuticals, have just published the results obtained if a new antibiotic named Teixobactin. This new antibiotic, is able to eliminate the colitis, tuberculosis, conjunctivitis, meningitis or pneumonia-causing…Details